Veteriner farmakoloji ve toksikolojide transport proteinleri

Aktif taşıma, ilaçların dağılımında önemli yolaklardan biridir. Konsantrasyon farkına karşı olan bu tip geçişte endotel ve epitel hücrelerin her iki yüzünde bulunan spesifik taşıyıcı proteinler görev alır. Taşımaya aracılık eden proteinler ABC (ATP-binding Casette Family) ve SLC (Solute Carrier family) süper ailesi olmak üzere 2 büyük gen ailesi tarafından kodlanırlar. Bu proteinlerin hücresel lokalizasyonları, yapıları ve fonksiyonları özellikle knock-out farelerde gösterilmiştir. Taşıyıcı proteinlerden ABC Süper ailesi üyesi olan P-glikoprotein, ilk olarak kanser ilaçlarına karşı dirençli tümör hücrelerinde tanımlanmıştır. Pglikoprotein’in endojen maddelerin taşınmasına aracılık ederek fizyolojik proseslerde rol aldığı ve yaşamsal öneme sahip olduğu belirlenmiştir. Ayrıca bu proteinlerin ilaç farmakokinetiğinde de önemli rol oynadıkları gösterilmiştir. Bu yazıda mümkün olduğunca veteriner pratiğe yönelik örneklerle; emilim, dağılım, metabolizma ve atılım sırasında aynı taşıyıcı proteine yarışma nedeniyle oluşabilecek farmakokinetik etkileşmeler açıklanmaya çalışılacak böylelikle veteriner farmakoloji ve toksikoloji yönünden öneme sahip ilaç ve zehirlerin farmakokinetiğinde taşıyıcı proteinlerin rolü vurgulanacaktır.

Transport proteins in veterinary pharmacology and toxicology

Active transport is one of the important process for drug dispositions. Specific membrane transporters serve as a carrier for both surface of epithelial and endothelial cells membrane at the active transport which is against to concentration gradient. These transport proteins are coded by two major super gene family called ABC Super family (ATP-binding family) and SLC Super Family (Solute Carrier Family). These proteins’ cellular localization, structure and function are demonstrated at recent investigations especially on knock-out mice. For the first time P-gp, is a member of ABC super family, was described in tumor cells which have resistance against the antineoplastic drugs. It is shown that P-gp has a vital role at physiological process by transporting endogen molecules. Furthermore, it has been shown that it has an important function at the pharmacokinetic of xenobiotics. At this review we will focus on pharmacokinetic interaction that could be occur in absorption, distribution, biotransformation and elimination, because of competition for binding to same transport protein with examples related to veterinary practices as far as possible. Thus, the role of transport proteins in pharmacokinetics of drugs and toxins which have veterinary importance will be underlined

___

  • 1. Amatori,F.M., Meucci, V.,Giusiani,M., Soldani, G., Corazza, M.,Giorgi, M. Effect of Grapefruit Juice on the Pharmacokinetics of Cyclosporine in Dogs.Vet Rec, 2004; 154, 190- 181
  • 2. Benet, L.Z., Cummins, C.L., Wu, C.Y. Unmasking the Dynamic Interplay Between Efflux Transporters and Metabolic Enzymes. Int J Pharm, 2004;277, 3-9
  • 3. Breedveld,P., Pluim, D., Cipriani, G., Wielinga, P., Tellingen, O., Schinkel, A.H., Schellens, J.H.M. The Effects of Bcrp1 (Abcg2) on the In vivo Pharmacokinetics and Brain Penetration of Imatinib Mestylate (Gleevec): Implacations for the Use of Breast Cancer Resistance Protein and P-Glycoprotein Inhibitors to Enable the Brain Penetration of Imatinib in Patients. Cancer Res, 2005; 65(7), 2577-2582
  • 4. Brunton, LL, Parker, KL, Buxton, I.L.O. and Blumenthal, D.K. (Eds) Goodman & Gilman's The Pharmacological Basis of Therapeutics, 11.baskı (Online). Erişim tarihi 16 Ekim 2006 www.accessmedicine.com Murat YILDIRIM, Elif ŞAHİN 16
  • 5. Cascorbi, I. Role of pharmacogenetics of ATP- binding cassette transporters in pharmacokinetics of drugs. Pharmacol Therapeut, 2006
  • 6. Deeley,R.G., Cole,S.P.C. Substrate recognition and transport by multidrug resistance protein 1 ( ABCC1). FEBS Lett, 2006; 580, 1103-1111
  • 7. Geyer, J., Klintzsch, S., Meerkamp, K., Wöhlke,A., Distl, O., Moritz, A. Detection of of the nt 230 (del4) MDR1 mutation in White Swiss Shepherd dogs: case reports of doramectin toxicosis, breed disposition and microsatellite analysis. J.Vet. Pharmacol. Therap., 2007; 30, 482-485
  • 8. Giorgi, M., Meucci, V., Vaccaro, E., Mengozzi, G., Giusiani, M., Soldani, G. Effect of liquid and freze-dried grapefruit juice on the pharmacokinetics of praziquentel and its metabolite 4’-OH praziquantel in beagle dogs. Pharmacol Res, 2003; 47, 87-92
  • 9. Jonker, J.W., Smit,J.W., Brinkhuis R.F., Maliepaard, M., Beijnen, J.H., Schellens J.H.M., Schinkel, A.H. Role of breast cancer resistance protein in the bioavaillability and fetal penetration of topotecan. J Natl Cancer I, 2000; 92(20), 1651-1656
  • 10. Haritova, A.M., Schrıckx, J., Lashev, L., Fınk-Gremmels, J. ABC Efflux Transporters: Pgp, MRP2 and BCRP- the 3rd Dimension in Kinetic not only of Fluoroquinolones. Bulg J Vet Med, 2006; 9(4), 223-242
  • 11. Kaya, S. Farmakokinetik. Veteriner Hekimliğinde Farmakoloji. Ed. Kaya, S., Pirinçci, İ., Bilgili, A., Ankara, Medisan Yayınları, 2002, 60-65
  • 12. Lancet ,J., Baer, M.R., Cripe, L.D., et al: Phase I/II Pharmacodynamic Study of the Pglycoprotein (Pgp) Inhibitor Zosuquidar Administered by Continuous Infusion (CIV) with Daunorubicin (DNR) and Cytarabine (ARA-C) as Primary Therapy in Older Patients with Acute Myeloid Leukemia (AML). The American Society of Hematology 48th Annual Meeting and Exposition; .2006; Aralık 9-12,; Orlando, FL. Abstract 422.
  • 13. Lin, J.H., Chiba, M., Chen, I., Nıshime, J.A., Deluna, F.A., Yamazakı, M.,Lin, Y.J. Effect of Dexamethasone on the Intestinal First-pass Metabolism of Indınavir in Rats: Evidence of Cytocrome P-450 a and P-glycoprotein Induction. Drug Metab Dispos, 1999; 27 (10) , 1187-1193
  • 14. Mao, Q., Unadkat, J.D. Role of the Breast Cancer Resistance Protein (ABCG2) in Drug Transport. AAPS J, 2005; 7(1) Article 12, E118-E129.
  • 15. McEntee, M., Silverman, J.A., Rassnick, K., Zgola, M., Chan,A.O., Tau, P.T., Page, R.L. Enhanced Bioavailability of Oral Docetaxel by Co-adminitration of Cyclosporin A in Dogs and Rats. Vet Comp Oncol. 2003; 2,105-112
  • 16. Mealey, K.L. Therapeutic Implications of the MDR-1 Gene. J. Vet. Pharmacol. Therap., 2004; 27, 257-264
  • 17. Miller, D.S. Xenobiotic Export Pumps, Endothelin Signaling, and Tubular Nephrotoxicants- A Case of Molecular Hijacking. J Biochem Mol Toxicol, 2002;16(3), 121-127
  • 18. Mizuno, N., Niwa. T., Yotsumoto, Y., Sugiyama, Y. Impact of Drug Transporter Studies on Drug Discovery and Development. Pharmocol Rev 2003; 55(3), 425-461.
  • 19. Pulido, M.M., Molina, A.J., Merino, G., Mendoza, G., Prieto, J.G., Alvarez, A.I. Interaction of Enrofloxacin with Breast Cancer Resistance Protein (BCRP/ABCG2): Influence of Flavonoids and Role in Milk Secretion in Sheep. J. Vet. Pharmacol. Therap., 2006; 29, 279-287
  • 20. Sadeque, A.J.M., Wandel, C., He, H., Shah, S.,Woc, A.J.J. Increased Drug Delivery to the Brain by P-glycoprotein Inhibition. Clin Pharmacol Ther. 2000;68,231-237
  • 21. Sartor, L.L., Bentjen, S.A., Trepanier, L.,Mealey, K.L. Loperamide Toxicity in a Collie with MDR1 Mutation Associated with Ivermectin Sensitivity. J. Vet. Intern. Med. 2004; 18, 117-118
  • 22. Schinkela, A.H., Smita J.M.M., Tellingenb, O., Beijnenc, J.H., Wagenaara, E., Deemtera, L., Mola, C.A.A.M., Valkd, M.A., Robanus-Maandagd, E.C., Rieled, H.P.J., Bernsd and P. Borsta A.J.M.. Disruption of the Mouse mdr1a P-glycoprotein gene Leads to a Deficiency in the Blood-brain Barrier and to Increased Sensitivity to Drugs. Cell, 1994; 77(4), 491-502.
  • 23. Takano, M.,Yumoto, R., Murakami, T. Expression and Function of Efflux Drug Transporters in the Intestine. Pharmacol Therapeut, 2006; 109, 137-161
  • 24. van Herwaarden, A.E., Wagenaar, E., Karnekamp, B., Merino, G., Jonker, J.W., Schinkel, A.H. Breast Cancer Resistance Protein (Bcrp1/Abcg2) Reduces Systemic Exposure of the Dietary Carcinogens Aflatoxin B1, IQ and Trp-P-1 but also Mediates Their Secretion into Breast Milk, Carcinogenesis. 2006; 27(1), 123-130